{
    "title": "Axsome's depression drug enters competitive market after U.S. approval",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11127045/Axsomes-depression-drug-gets-FDA-approval.html",
    "date": "2022-08-19",
    "keywords": [
        "depression",
        "drug",
        "treatment",
        "company",
        "approval",
        "disorder",
        "market",
        "therapy",
        "friday",
        "option",
        "quarter",
        "trade",
        "auvelity",
        "class",
        "week",
        "edge",
        "effect",
        "investment",
        "field",
        "analyst",
        "yatin",
        "client",
        "note",
        "mdd",
        "sadness",
        "prevalence",
        "start",
        "covid19",
        "johnson",
        "amp",
        "spravato",
        "glutamate",
        "latestage",
        "trial",
        "agency",
        "companys",
        "application",
        "year",
        "review",
        "axsome",
        "ability",
        "pill",
        "home",
        "uptake",
        "list",
        "price",
        "warning",
        "risk",
        "adult",
        "anil",
        "dsilva"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}